Literature DB >> 32588342

Advanced maternal age impacts physiologic adaptations to pregnancy in vervet monkeys.

Maren Plant1, Cecilia Armstrong1, Alistaire Ruggiero1, Chrissy Sherrill1, Beth Uberseder1, Rachel Jeffries1, Justin Nevarez1, Matthew J Jorgensen1, Kylie Kavanagh1, Matthew A Quinn2.   

Abstract

The trend to delay pregnancy in the USA has resulted in the number of advanced maternal age (AMA) pregnancies to also increase. In humans, AMA is associated with a variety of pregnancy-related pathologies such as preeclampsia (PE). While AMA is known to be a factor which contributes to the development of pregnancy-induced diseases, the molecular and cellular mechanisms giving rise to this phenomenon are still very limited. This is due in part to lack of a preclinical model which has physiologic relevance to human pregnancy while also allowing control of environmental and genetic variability inherent in human studies. To determine potential physiologic relevance of the vervet/African green monkey (Chlorocebus aethiops sabaeus) as a preclinical model to study the effects of AMA on adaptations to pregnancy, thirteen age-diverse pregnant vervet monkeys (3-16 years old) were utilized to measure third trimester blood pressure (BP), complete blood count, iron measurements, and hormone levels. Significant associations were observed between third trimester diastolic BP and maternal age. Furthermore, the presence of leukocytosis with enhanced circulating neutrophils was observed in AMA mothers compared to younger mothers. Moreover, we observed a negative relationship between maternal age and estradiol, progesterone, and cortisol levels. Finally, offspring born to AMA mothers displayed a postnatal growth retardation phenotype. These studies demonstrate physiologic impairment in the adaptation to pregnancy in AMA vervet/African green monkeys. Our data indicate that the vervet/African green monkey may serve as a useful preclinical model and tool for deciphering pathological mediators of maternal disease in AMA pregnancy.

Entities:  

Keywords:  Advanced maternal age; Leukocytosis; Preeclampsia

Mesh:

Year:  2020        PMID: 32588342      PMCID: PMC7732933          DOI: 10.1007/s11357-020-00219-8

Source DB:  PubMed          Journal:  Geroscience        ISSN: 2509-2723            Impact factor:   7.713


  90 in total

1.  Mean Age of Mothers is on the Rise: United States, 2000-2014.

Authors:  T J Mathews; Brady E Hamilton
Journal:  NCHS Data Brief       Date:  2016-01

Review 2.  Immunology of preeclampsia.

Authors:  Leif Matthiesen; Göran Berg; Jan Ernerudh; Christina Ekerfelt; Yvonne Jonsson; Surendra Sharma
Journal:  Chem Immunol Allergy       Date:  2005

3.  Pregnancy outcome at age 40 and older.

Authors:  A Bianco; J Stone; L Lynch; R Lapinski; G Berkowitz; R L Berkowitz
Journal:  Obstet Gynecol       Date:  1996-06       Impact factor: 7.661

4.  Blood Pressure Profile 1 Year After Severe Preeclampsia.

Authors:  Laura Benschop; Johannes J Duvekot; Jorie Versmissen; Valeska van Broekhoven; Eric A P Steegers; Jeanine E Roeters van Lennep
Journal:  Hypertension       Date:  2018-03       Impact factor: 10.190

5.  Sex Differences in Heart Failure With Preserved Ejection Fraction Pathophysiology: A Detailed Invasive Hemodynamic and Echocardiographic Analysis.

Authors:  Anna L Beale; Shane Nanayakkara; Louise Segan; Justin A Mariani; Micha T Maeder; Vanessa van Empel; Donna Vizi; Shona Evans; Carolyn S P Lam; David M Kaye
Journal:  JACC Heart Fail       Date:  2019-03       Impact factor: 12.035

6.  Aging African green monkeys manifest transcriptional, pathological, and cognitive hallmarks of human Alzheimer's disease.

Authors:  Paige E Cramer; Renee C Gentzel; Keith Q Tanis; Joshua Vardigan; Yi Wang; Brett Connolly; Philip Manfre; Kenneth Lodge; John J Renger; Celina Zerbinatti; Jason M Uslaner
Journal:  Neurobiol Aging       Date:  2017-12-20       Impact factor: 4.673

7.  Effect of early-onset preeclampsia on cardiovascular risk in the fifth decade of life.

Authors:  Anouk Bokslag; Pim W Teunissen; Constantijn Franssen; Floortje van Kesteren; Otto Kamp; Wessel Ganzevoort; Walter J Paulus; Christianne J M de Groot
Journal:  Am J Obstet Gynecol       Date:  2017-02-14       Impact factor: 8.661

8.  Steroid profiling in preeclamptic women: evidence for aromatase deficiency.

Authors:  Alexandre Hertig; Philippe Liere; Nathalie Chabbert-Buffet; Julie Fort; Antoine Pianos; Bernard Eychenne; Annie Cambourg; Michael Schumacher; Nadia Berkane; Guillaume Lefevre; Serge Uzan; Eric Rondeau; Patrick Rozenberg; Marie-Edith Rafestin-Oblin
Journal:  Am J Obstet Gynecol       Date:  2010-08-05       Impact factor: 8.661

9.  Prepregnancy body mass index, gestational weight gain, and risk of hypertensive pregnancy among Latina women.

Authors:  Renée Turzanski Fortner; Penelope Pekow; Caren G Solomon; Glenn Markenson; Lisa Chasan-Taber
Journal:  Am J Obstet Gynecol       Date:  2008-12-13       Impact factor: 8.661

10.  Recurrence of pre-eclampsia and the risk of future hypertension and cardiovascular disease: a systematic review and meta-analysis.

Authors:  L Brouwers; A J van der Meiden-van Roest; C Savelkoul; T E Vogelvang; A T Lely; A Franx; B B van Rijn
Journal:  BJOG       Date:  2018-08-10       Impact factor: 6.531

View more
  3 in total

Review 1.  Pregnancy, preeclampsia and maternal aging: From epidemiology to functional genomics.

Authors:  Eliza C Miller; Ashley Wilczek; Natalie A Bello; Sarah Tom; Ronald Wapner; Yousin Suh
Journal:  Ageing Res Rev       Date:  2021-12-03       Impact factor: 10.895

2.  Steroidomics of Pregnant Women at Advanced Age.

Authors:  Bin Yu; Fang Guo; Yuqi Yang; Wei Long; Jun Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-23       Impact factor: 5.555

3.  The Effect of Tauroursodeoxycholic Acid (TUDCA) Treatment on Pregnancy Outcomes and Vascular Function in a Rat Model of Advanced Maternal Age.

Authors:  Mazhar Pasha; Raven Kirschenman; Amy Wooldridge; Floor Spaans; Christy-Lynn M Cooke; Sandra T Davidge
Journal:  Antioxidants (Basel)       Date:  2022-06-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.